Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 187 entries
Sorted by: Best Match Show Resources per page
Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Schindler C, Birkenfeld AL, Hanefeld M, Schatz U, Köhler C, Grüneberg M, Tschöpe D, Blüher M, Hasslacher C, Bornstein SR.
PMID: 30523582
Diabetes Ther. 2019 Feb;10(1):329-331. doi: 10.1007/s13300-018-0546-6.

In the original publication, the text in Table 2 stated 'Hypersensitivity to the active substance, to Ferinject, or to any of its excipients'.

Cite
Schindler C, Birkenfeld AL, Hanefeld M, et al. Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol. Diabetes Ther. 2019;10(1):329-331doi: 10.1007/s13300-018-0546-6.
Schindler, C., Birkenfeld, A. L., Hanefeld, M., Schatz, U., Köhler, C., Grüneberg, M., Tschöpe, D., Blüher, M., Hasslacher, C., & Bornstein, S. R. (2019). Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol. Diabetes therapy : research, treatment and education of diabetes and related disorders, 10(1), 329-331. https://doi.org/10.1007/s13300-018-0546-6
Schindler, Christoph, et al. "Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 10,1 (2019): 329-331. doi: https://doi.org/10.1007/s13300-018-0546-6
Schindler C, Birkenfeld AL, Hanefeld M, Schatz U, Köhler C, Grüneberg M, Tschöpe D, Blüher M, Hasslacher C, Bornstein SR. Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol. Diabetes Ther. 2019 Feb;10(1):329-331. doi: 10.1007/s13300-018-0546-6. PMID: 30523582; PMCID: PMC6349274.
Copy Download .nbib Format: NLM
Enhanced growth factor expression in chronic diabetic wounds treated by cold atmospheric plasma.

Diabetic medicine : a journal of the British Diabetic Association

Hiller J, Stratmann B, Timm J, Costea TC, Tschoepe D.
PMID: 35007358
Diabet Med. 2022 Jan 10;e14787. doi: 10.1111/dme.14787. Epub 2022 Jan 10.

AIMS: Cold atmospheric plasma (CAP) has been proven to enhance wound healing in superficial, chronically infected, diabetic foot ulcers. We aimed to investigate the molecular drivers responsible for this macroscopically observed improvement in diabetic wound healing.METHODS: Wound exudate was...

Cite
Hiller J, Stratmann B, Timm J, et al. Enhanced growth factor expression in chronic diabetic wounds treated by cold atmospheric plasma. Diabet Med. 2022;e14787doi: 10.1111/dme.14787.
Hiller, J., Stratmann, B., Timm, J., Costea, T. C., & Tschoepe, D. (2022). Enhanced growth factor expression in chronic diabetic wounds treated by cold atmospheric plasma. Diabetic medicine : a journal of the British Diabetic Association, e14787. https://doi.org/10.1111/dme.14787
Hiller, Jonas, et al. "Enhanced growth factor expression in chronic diabetic wounds treated by cold atmospheric plasma." Diabetic medicine : a journal of the British Diabetic Association vol. (2022): e14787. doi: https://doi.org/10.1111/dme.14787
Hiller J, Stratmann B, Timm J, Costea TC, Tschoepe D. Enhanced growth factor expression in chronic diabetic wounds treated by cold atmospheric plasma. Diabet Med. 2022 Jan 10;e14787. doi: 10.1111/dme.14787. Epub 2022 Jan 10. PMID: 35007358.
Copy Download .nbib Format: NLM
Peripheral oscillometric arterial performance does not depict coronary status in patients with type 2 diabetes mellitus.

Diabetes & vascular disease research

Jaeger M, Stratmann B, Tschoepe D.
PMID: 34825586
Diab Vasc Dis Res. 2021 Nov-Dec;18(6):14791641211046522. doi: 10.1177/14791641211046522.

BACKGROUND: Arterial stiffness is associated with cardiovascular events. Matrix metalloproteases (MMPs), their tissue inhibitors (TIMPs) and galectin-3 are involved in the pathogenesis of end organ damage. This study aimed to evaluate the contribution of arterial stiffness, MMPs, TIMPs and...

Cite
Jaeger M, Stratmann B, Tschoepe D. Peripheral oscillometric arterial performance does not depict coronary status in patients with type 2 diabetes mellitus. Diab Vasc Dis Res. 2021;18(6):14791641211046522doi: 10.1177/14791641211046522.
Jaeger, M., Stratmann, B., & Tschoepe, D. (2021). Peripheral oscillometric arterial performance does not depict coronary status in patients with type 2 diabetes mellitus. Diabetes & vascular disease research, 18(6), 14791641211046522. https://doi.org/10.1177/14791641211046522
Jaeger, Magdalene, et al. "Peripheral oscillometric arterial performance does not depict coronary status in patients with type 2 diabetes mellitus." Diabetes & vascular disease research vol. 18,6 (2021): 14791641211046522. doi: https://doi.org/10.1177/14791641211046522
Jaeger M, Stratmann B, Tschoepe D. Peripheral oscillometric arterial performance does not depict coronary status in patients with type 2 diabetes mellitus. Diab Vasc Dis Res. 2021 Nov-Dec;18(6):14791641211046522. doi: 10.1177/14791641211046522. PMID: 34825586.
Copy Download .nbib Format: NLM
Diffusion-weighted Imaging Allows for Downgrading MR BI-RADS 4 Lesions in Contrast-enhanced MRI of the Breast to Avoid Unnecessary Biopsy.

Clinical cancer research : an official journal of the American Association for Cancer Research

Clauser P, Krug B, Bickel H, Dietzel M, Pinker K, Neuhaus VF, Marino MA, Moschetta M, Troiano N, Helbich TH, Baltzer PAT.
PMID: 33446565
Clin Cancer Res. 2021 Apr 01;27(7):1941-1948. doi: 10.1158/1078-0432.CCR-20-3037. Epub 2021 Jan 14.

PURPOSE: Diffusion-weighted imaging with the calculation of an apparent diffusion coefficient (ADC) has been proposed as a quantitative biomarker on contrast-enhanced MRI (CE-MRI) of the breast. There is a need to approve a generalizable ADC cutoff. The purpose of...

Cite
Clauser P, Krug B, Bickel H, et al. Diffusion-weighted Imaging Allows for Downgrading MR BI-RADS 4 Lesions in Contrast-enhanced MRI of the Breast to Avoid Unnecessary Biopsy. Clin Cancer Res. 2021;27(7):1941-1948doi: 10.1158/1078-0432.CCR-20-3037.
Clauser, P., Krug, B., Bickel, H., Dietzel, M., Pinker, K., Neuhaus, V. F., Marino, M. A., Moschetta, M., Troiano, N., Helbich, T. H., & Baltzer, P. A. T. (2021). Diffusion-weighted Imaging Allows for Downgrading MR BI-RADS 4 Lesions in Contrast-enhanced MRI of the Breast to Avoid Unnecessary Biopsy. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(7), 1941-1948. https://doi.org/10.1158/1078-0432.CCR-20-3037
Clauser, Paola, et al. "Diffusion-weighted Imaging Allows for Downgrading MR BI-RADS 4 Lesions in Contrast-enhanced MRI of the Breast to Avoid Unnecessary Biopsy." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,7 (2021): 1941-1948. doi: https://doi.org/10.1158/1078-0432.CCR-20-3037
Clauser P, Krug B, Bickel H, Dietzel M, Pinker K, Neuhaus VF, Marino MA, Moschetta M, Troiano N, Helbich TH, Baltzer PAT. Diffusion-weighted Imaging Allows for Downgrading MR BI-RADS 4 Lesions in Contrast-enhanced MRI of the Breast to Avoid Unnecessary Biopsy. Clin Cancer Res. 2021 Apr 01;27(7):1941-1948. doi: 10.1158/1078-0432.CCR-20-3037. Epub 2021 Jan 14. PMID: 33446565; PMCID: PMC8406278.
Copy Download .nbib Format: NLM
[Quality assurance in dMMR and MSI diagnostics].

Der Pathologe

Jöhrens K, Dietmaier W, Utpatel K, Dietel M, Rüschoff J, Fischer J.
PMID: 33835236
Pathologe. 2021 Jul;42(4):405-413. doi: 10.1007/s00292-021-00930-z. Epub 2021 Apr 09.

Deficient mismatch repair (dMMR) and microsatellite instability (MSI) have therapeutic relevance not only for colorectal carcinomas but also for carcinomas of other entities (endometrium, biliary tract, pancreas). In order to guarantee the knowledge and good technical quality necessary for...

Cite
Jöhrens K, Dietmaier W, Utpatel K, et al. Qualitätssicherung in der dMMR- und MSI-Diagnostik. [Quality assurance in dMMR and MSI diagnostics]. Pathologe. 2021;42(4):405-413doi: 10.1007/s00292-021-00930-z.
Jöhrens, K., Dietmaier, W., Utpatel, K., Dietel, M., Rüschoff, J., & Fischer, J. (2021). Qualitätssicherung in der dMMR- und MSI-Diagnostik. [Quality assurance in dMMR and MSI diagnostics]. Der Pathologe, 42(4), 405-413. https://doi.org/10.1007/s00292-021-00930-z
Jöhrens, Korinna, et al. "Qualitätssicherung in der dMMR- und MSI-Diagnostik." [Quality assurance in dMMR and MSI diagnostics]. Der Pathologe vol. 42,4 (2021): 405-413. doi: https://doi.org/10.1007/s00292-021-00930-z
Jöhrens K, Dietmaier W, Utpatel K, Dietel M, Rüschoff J, Fischer J. Qualitätssicherung in der dMMR- und MSI-Diagnostik. [Quality assurance in dMMR and MSI diagnostics]. Pathologe. 2021 Jul;42(4):405-413. doi: 10.1007/s00292-021-00930-z. Epub 2021 Apr 09. German. PMID: 33835236.
Copy Download .nbib Format: NLM
Determination of the Shear Modulus of Thin Polymer Films with a Quartz Crystal Microbalance: Application to UV-Curing.

Analytical chemistry

Petri J, Johannsmann D.
PMID: 30576109
Anal Chem. 2019 Jan 15;91(2):1595-1602. doi: 10.1021/acs.analchem.8b05037. Epub 2019 Jan 04.

The photoinduced curing of a light-sensitive varnish was followed, based on a change of the film's shear modulus, G, as determined with a quartz crystal microbalance (QCM). The film thickness was in the range of a few hundred nanometers....

Cite
Petri J, Johannsmann D. Determination of the Shear Modulus of Thin Polymer Films with a Quartz Crystal Microbalance: Application to UV-Curing. Anal Chem. 2019;91(2):1595-1602doi: 10.1021/acs.analchem.8b05037.
Petri, J., & Johannsmann, D. (2019). Determination of the Shear Modulus of Thin Polymer Films with a Quartz Crystal Microbalance: Application to UV-Curing. Analytical chemistry, 91(2), 1595-1602. https://doi.org/10.1021/acs.analchem.8b05037
Petri, Judith, and Johannsmann, Diethelm. "Determination of the Shear Modulus of Thin Polymer Films with a Quartz Crystal Microbalance: Application to UV-Curing." Analytical chemistry vol. 91,2 (2019): 1595-1602. doi: https://doi.org/10.1021/acs.analchem.8b05037
Petri J, Johannsmann D. Determination of the Shear Modulus of Thin Polymer Films with a Quartz Crystal Microbalance: Application to UV-Curing. Anal Chem. 2019 Jan 15;91(2):1595-1602. doi: 10.1021/acs.analchem.8b05037. Epub 2019 Jan 04. PMID: 30576109.
Copy Download .nbib Format: NLM
Influence of 99m-Tc-Nanocolloid Activity Concentration on Sentinel Lymph Node Detection in Endometrial Cancer: A Quantitative SPECT/CT Study.

Diagnostics (Basel, Switzerland)

Sahbai S, Fiz F, Taran F, Brucker S, Wallwiener D, Kupferschlaeger J, La Fougère C, Dittmann H.
PMID: 32947918
Diagnostics (Basel). 2020 Sep 16;10(9). doi: 10.3390/diagnostics10090700.

This study evaluates quantitative combined single photon emission tomography/computed x-ray tomography (SPECT/CT) to assess the influence of radiotracer concentration on detection of sentinel lymph nodes (SLN) in endometrial cancer (EC). Eighty EC patients underwent pericervical 99m-Tc-nanocolloid injection followed by...

Cite
Sahbai S, Fiz F, Taran F, et al. Influence of 99m-Tc-Nanocolloid Activity Concentration on Sentinel Lymph Node Detection in Endometrial Cancer: A Quantitative SPECT/CT Study. Diagnostics (Basel). 2020;10(9)doi: 10.3390/diagnostics10090700.
Sahbai, S., Fiz, F., Taran, F., Brucker, S., Wallwiener, D., Kupferschlaeger, J., La Fougère, C., & Dittmann, H. (2020). Influence of 99m-Tc-Nanocolloid Activity Concentration on Sentinel Lymph Node Detection in Endometrial Cancer: A Quantitative SPECT/CT Study. Diagnostics (Basel, Switzerland), 10(9), . https://doi.org/10.3390/diagnostics10090700
Sahbai, Samine, et al. "Influence of 99m-Tc-Nanocolloid Activity Concentration on Sentinel Lymph Node Detection in Endometrial Cancer: A Quantitative SPECT/CT Study." Diagnostics (Basel, Switzerland) vol. 10,9 (2020). doi: https://doi.org/10.3390/diagnostics10090700
Sahbai S, Fiz F, Taran F, Brucker S, Wallwiener D, Kupferschlaeger J, La Fougère C, Dittmann H. Influence of 99m-Tc-Nanocolloid Activity Concentration on Sentinel Lymph Node Detection in Endometrial Cancer: A Quantitative SPECT/CT Study. Diagnostics (Basel). 2020 Sep 16;10(9). doi: 10.3390/diagnostics10090700. PMID: 32947918; PMCID: PMC7555748.
Copy Download .nbib Format: NLM
Compressional-Wave Effects in the Operation of a Quartz Crystal Microbalance in Liquids:Dependence on Overtone Order.

Sensors (Basel, Switzerland)

Kowarsch R, Suhak Y, Eduarte LC, Mansour M, Meyer F, Peschel A, Fritze H, Rembe C, Johannsmann D.
PMID: 32365649
Sensors (Basel). 2020 Apr 29;20(9). doi: 10.3390/s20092535.

The operation of the quartz crystal microbalance (QCM) in liquids is plagued by small flexural admixtures to the thickness-shear deformation. The resonator surface moves not only in the transverse direction, but also along the surface normal, thereby emitting compressional...

Cite
Kowarsch R, Suhak Y, Eduarte LC, et al. Compressional-Wave Effects in the Operation of a Quartz Crystal Microbalance in Liquids:Dependence on Overtone Order. Sensors (Basel). 2020;20(9)doi: 10.3390/s20092535.
Kowarsch, R., Suhak, Y., Eduarte, L. C., Mansour, M., Meyer, F., Peschel, A., Fritze, H., Rembe, C., & Johannsmann, D. (2020). Compressional-Wave Effects in the Operation of a Quartz Crystal Microbalance in Liquids:Dependence on Overtone Order. Sensors (Basel, Switzerland), 20(9), . https://doi.org/10.3390/s20092535
Kowarsch, Robert, et al. "Compressional-Wave Effects in the Operation of a Quartz Crystal Microbalance in Liquids:Dependence on Overtone Order." Sensors (Basel, Switzerland) vol. 20,9 (2020). doi: https://doi.org/10.3390/s20092535
Kowarsch R, Suhak Y, Eduarte LC, Mansour M, Meyer F, Peschel A, Fritze H, Rembe C, Johannsmann D. Compressional-Wave Effects in the Operation of a Quartz Crystal Microbalance in Liquids:Dependence on Overtone Order. Sensors (Basel). 2020 Apr 29;20(9). doi: 10.3390/s20092535. PMID: 32365649; PMCID: PMC7249204.
Copy Download .nbib Format: NLM
Trans-Mucosal Efficacy of Non-Thermal Plasma Treatment on Cervical Cancer Tissue and Human Cervix Uteri by a Next Generation Electrosurgical Argon Plasma Device.

Cancers

Wenzel T, Carvajal Berrio DA, Reisenauer C, Layland S, Koch A, Wallwiener D, Brucker SY, Schenke-Layland K, Brauchle EM, Weiss M.
PMID: 31979067
Cancers (Basel). 2020 Jan 22;12(2). doi: 10.3390/cancers12020267.

Non-invasive physical plasma (NIPP) generated by non-thermally operated electrosurgical argon plasma sources is a promising treatment for local chronic inflammatory, precancerous and cancerous diseases. NIPP-enabling plasma sources are highly available and medically approved. The purpose of this study is...

Cite
Wenzel T, Carvajal Berrio DA, Reisenauer C, et al. Trans-Mucosal Efficacy of Non-Thermal Plasma Treatment on Cervical Cancer Tissue and Human Cervix Uteri by a Next Generation Electrosurgical Argon Plasma Device. Cancers (Basel). 2020;12(2)doi: 10.3390/cancers12020267.
Wenzel, T., Carvajal Berrio, D. A., Reisenauer, C., Layland, S., Koch, A., Wallwiener, D., Brucker, S. Y., Schenke-Layland, K., Brauchle, E. M., & Weiss, M. (2020). Trans-Mucosal Efficacy of Non-Thermal Plasma Treatment on Cervical Cancer Tissue and Human Cervix Uteri by a Next Generation Electrosurgical Argon Plasma Device. Cancers, 12(2), . https://doi.org/10.3390/cancers12020267
Wenzel, Thomas, et al. "Trans-Mucosal Efficacy of Non-Thermal Plasma Treatment on Cervical Cancer Tissue and Human Cervix Uteri by a Next Generation Electrosurgical Argon Plasma Device." Cancers vol. 12,2 (2020). doi: https://doi.org/10.3390/cancers12020267
Wenzel T, Carvajal Berrio DA, Reisenauer C, Layland S, Koch A, Wallwiener D, Brucker SY, Schenke-Layland K, Brauchle EM, Weiss M. Trans-Mucosal Efficacy of Non-Thermal Plasma Treatment on Cervical Cancer Tissue and Human Cervix Uteri by a Next Generation Electrosurgical Argon Plasma Device. Cancers (Basel). 2020 Jan 22;12(2). doi: 10.3390/cancers12020267. PMID: 31979067; PMCID: PMC7072402.
Copy Download .nbib Format: NLM
Author Correction: Reversible amyloids of pyruvate kinase couple cell metabolism and stress granule disassembly.

Nature cell biology

Cereghetti G, Wilson-Zbinden C, Kissling VM, Diether M, Arm A, Yoo H, Piazza I, Saad S, Picotti P, Drummond DA, Sauer U, Dechant R, Peter M.
PMID: 34702981
Nat Cell Biol. 2021 Oct 26; doi: 10.1038/s41556-021-00799-3. Epub 2021 Oct 26.

No abstract available.

Cite
Cereghetti G, Wilson-Zbinden C, Kissling VM, et al. Author Correction: Reversible amyloids of pyruvate kinase couple cell metabolism and stress granule disassembly. Nat Cell Biol. 2021;doi: 10.1038/s41556-021-00799-3.
Cereghetti, G., Wilson-Zbinden, C., Kissling, V. M., Diether, M., Arm, A., Yoo, H., Piazza, I., Saad, S., Picotti, P., Drummond, D. A., Sauer, U., Dechant, R., & Peter, M. (2021). Author Correction: Reversible amyloids of pyruvate kinase couple cell metabolism and stress granule disassembly. Nature cell biology, . https://doi.org/10.1038/s41556-021-00799-3
Cereghetti, Gea, et al. "Author Correction: Reversible amyloids of pyruvate kinase couple cell metabolism and stress granule disassembly." Nature cell biology vol. (2021). doi: https://doi.org/10.1038/s41556-021-00799-3
Cereghetti G, Wilson-Zbinden C, Kissling VM, Diether M, Arm A, Yoo H, Piazza I, Saad S, Picotti P, Drummond DA, Sauer U, Dechant R, Peter M. Author Correction: Reversible amyloids of pyruvate kinase couple cell metabolism and stress granule disassembly. Nat Cell Biol. 2021 Oct 26; doi: 10.1038/s41556-021-00799-3. Epub 2021 Oct 26. PMID: 34702981.
Copy Download .nbib Format: NLM
Stress-induced growth rate reduction restricts metabolic resource utilization to modulate osmo-adaptation time.

Cell reports

Bonny AR, Kochanowski K, Diether M, El-Samad H.
PMID: 33730573
Cell Rep. 2021 Mar 16;34(11):108854. doi: 10.1016/j.celrep.2021.108854.

A near-constant feature of stress responses is a downregulation or arrest of the cell cycle, resulting in transient growth slowdown. To investigate the role of growth slowdown in the hyperosmotic shock response of S. cerevisiae, we perturbed the G1/S...

Cite
Bonny AR, Kochanowski K, Diether M, et al. Stress-induced growth rate reduction restricts metabolic resource utilization to modulate osmo-adaptation time. Cell Rep. 2021;34(11):108854doi: 10.1016/j.celrep.2021.108854.
Bonny, A. R., Kochanowski, K., Diether, M., & El-Samad, H. (2021). Stress-induced growth rate reduction restricts metabolic resource utilization to modulate osmo-adaptation time. Cell reports, 34(11), 108854. https://doi.org/10.1016/j.celrep.2021.108854
Bonny, Alain R, et al. "Stress-induced growth rate reduction restricts metabolic resource utilization to modulate osmo-adaptation time." Cell reports vol. 34,11 (2021): 108854. doi: https://doi.org/10.1016/j.celrep.2021.108854
Bonny AR, Kochanowski K, Diether M, El-Samad H. Stress-induced growth rate reduction restricts metabolic resource utilization to modulate osmo-adaptation time. Cell Rep. 2021 Mar 16;34(11):108854. doi: 10.1016/j.celrep.2021.108854. PMID: 33730573.
Copy Download .nbib Format: NLM
Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status.

European journal of cancer (Oxford, England : 1990)

Hein A, Hartkopf AD, Emons J, Lux MP, Volz B, Taran FA, Overkamp F, Hadji P, Tesch H, Häberle L, Ettl J, Lüftner D, Wurmthaler LA, Wallwiener M, Müller V, Beckmann MW, Belleville E, Wimberger P, Hielscher C, Kurbacher CM, Wuerstlein R, Thomssen C, Untch M, Fasching PA, Janni W, Fehm TN, Wallwiener D, Brucker SY, Schneeweiss A, Kolberg HC.
PMID: 34311211
Eur J Cancer. 2021 Sep;155:1-12. doi: 10.1016/j.ejca.2021.06.033. Epub 2021 Jul 23.

PURPOSE: Assessment of HER2 overexpression using immunohistochemistry (IHC) and/or in situ hybridisation (ISH) for the detection of HER2 amplifications is standard to identify patients for established HER2-directed treatments. Patients with lower HER2 expression levels have recently also become candidates...

Cite
Hein A, Hartkopf AD, Emons J, et al. Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status. Eur J Cancer. 2021;155:1-12doi: 10.1016/j.ejca.2021.06.033.
Hein, A., Hartkopf, A. D., Emons, J., Lux, M. P., Volz, B., Taran, F. A., Overkamp, F., Hadji, P., Tesch, H., Häberle, L., Ettl, J., Lüftner, D., Wurmthaler, L. A., Wallwiener, M., Müller, V., Beckmann, M. W., Belleville, E., Wimberger, P., Hielscher, C., Kurbacher, C. M., Wuerstlein, R., Thomssen, C., Untch, M., Fasching, P. A., Janni, W., Fehm, T. N., Wallwiener, D., Brucker, S. Y., Schneeweiss, A., & Kolberg, H. C. (2021). Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status. European journal of cancer (Oxford, England : 1990), 1551-12. https://doi.org/10.1016/j.ejca.2021.06.033
Hein, Alexander, et al. "Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status." European journal of cancer (Oxford, England : 1990) vol. 155 (2021): 1-12. doi: https://doi.org/10.1016/j.ejca.2021.06.033
Hein A, Hartkopf AD, Emons J, Lux MP, Volz B, Taran FA, Overkamp F, Hadji P, Tesch H, Häberle L, Ettl J, Lüftner D, Wurmthaler LA, Wallwiener M, Müller V, Beckmann MW, Belleville E, Wimberger P, Hielscher C, Kurbacher CM, Wuerstlein R, Thomssen C, Untch M, Fasching PA, Janni W, Fehm TN, Wallwiener D, Brucker SY, Schneeweiss A, Kolberg HC. Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status. Eur J Cancer. 2021 Sep;155:1-12. doi: 10.1016/j.ejca.2021.06.033. Epub 2021 Jul 23. PMID: 34311211.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 187 entries